On June 5, 2024, two experienced NASA astronauts went to the International Space Station (ISS) for an eight-day test flight. But things didn’t go as planned. A series of unexpected problems left ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

Mursla Bio, which recently announced the results of its 400-patient clinical trial, is not just evolving the science of liquid biopsies – the fast-track biotech is also creating a Cambridge-made ...

IndusInd Bank, which in the December-ended quarter saw a fall in interest income, profitability and asset quality, is in the midst of yet another negative event. The bank has reported ...